Cogentix Medical

1 Decision Maker · 2 Verified Contacts & Email Format

📍 Minnesota City, Minnesota, United StatesBiotechnology🗓 Est. 1987👥 101–250 employees

About Cogentix Medical

Cogentix Medical products have increased treatment efficiency and lowered patient risk.

Email Format

{first_name}.{last_name}@cogentixmedical.com — 100.0%

sarah.smith@cogentixmedical.com

Leadership & Decision Makers

Contact details of 1 Cogentix Medical decision makers

Rob Kill

Founder

Team & Specialists

Contact details of 1 Cogentix Medical team members

Vikki Jochim-Ruisch

Exec. Assistant to board member, Lewis C. Pell LinkedIn
  • Work email

    v****************h@cogentixmedical.com

General Emails

General company emails, e.g. customer support lines

    christa.blaisdell@cogentixmedical.com

    Unclassified inbox

    AR@cogentixmedical.com

    Unclassified inbox

    john.smith@cogentixmedical.com

    Unclassified inbox

    customercare@cogentixmedical.com

    Unclassified inbox

    intl.sales@cogentixmedical.com

    Sales Department

Similar Companies like Cogentix Medical

Bio-Techne

bio-techne.com
Biotechnology · Minneapolis, MN · Est. 1981 · 1001–5000 employees

HQ: Minneapolis, MN

Edwards Lifesciences

edwards.com
Biotechnology · Irvine, CA · Est. 1958 · 5001–10000 employees

HQ: Irvine, CA

Medtronic

medtronic.com
Biotechnology · Minneapolis, MN · Est. 1949 · Above 10001 employees

HQ: Minneapolis, MN

Kite Pharma

kitepharma.com
Biotechnology · Los Angeles, CA · Est. 2009 · 101–250 employees

HQ: Los Angeles, CA

Sorrento Therapeutics

sorrentotherapeutics.com
Pharmaceuticals · San Diego, CA · Est. 2006 · 101–250 employees · $500M–$1B

HQ: San Diego, CA

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 29/07/2025

+118662582182

Minnesota City, Minnesota, United States

Legal Name: Cogentix Medical, Inc.
Business Type: Delisted
Employees: 101-250
Rounds: Post-IPO Equity
Founded Date: 1987
Company Type: For Profit
Stock Symbol: NASDAQ:CGNT
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: +118662582182
Last Investment Activity: Jan 4, 2019
Investments Activity: Jan 4, 2019 Mar 12, 2018 Sep 29, 2017

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.